معرفی
Kirk Bergstrom is an Assistant Professor in the Department of Biology at the University of British Columbia's Okanagan campus, Faculty of Science. His research focuses on the complex relationship between host organisms and their microbial communities, with particular emphasis on the role of glycobiology in intestinal health. Based in ASC 373, he teaches undergraduate courses including BIOL420 Functional Glycoscience and BIOL314 Medical Microbiology, contributing to the education of future scientists in microbiology and related fields.
- Education: BSc from University of Northern British Columbia
- PhD from University of British Columbia
Dr. Bergstrom's research centers on the intestinal mucus system and how defects in this system contribute to susceptibility to infections, inflammatory bowel disease (IBD), and colon cancer. His work specifically investigates how the intestine utilizes key glycosyltransferases (Core-1 and Core-3 synthases) to decorate mucin proteins with sugars (glycans), promoting optimal mucus function that keeps microbes at a healthy distance from the gut lining. His laboratory employs advanced techniques including functional analysis of mucins and glycan biology, gut ecology, and state-of-the-art imaging and genetic modeling to probe host-microbiota interactions at multiple biological levels.
Analysis of his recent publications reveals a consistent research trajectory focused on mucin-type O-glycosylation and its critical role in maintaining gut homeostasis. His work spans from fundamental mechanisms of mucus barrier function to clinical implications for inflammatory bowel diseases and cancer. A significant trend in his research involves the development of non-invasive diagnostic approaches using fecal material to assess mucus barrier integrity in health and disease.
Scientific recognition includes:
- The Bhagirath Singh Early Career Award in Infection and Immunity (2024)
While Dr. Bergstrom serves as a graduate student supervisor, he is not currently accepting new graduate students. His research program has generated numerous high-impact publications in prestigious journals including Science, Nature Medicine, and Journal of Experimental Medicine. His work often involves collaborative efforts with researchers across multiple institutions, reflecting the interdisciplinary nature of microbiome research. Dr. Bergstrom's laboratory focuses on understanding how mucin-type O-glycans regulate formation and function of the intestinal mucus system, with goals aimed at increasing knowledge of fundamental roles of mucins in gut health and developing novel interventions for IBD and cancer patients.
